EGFR and cancer: In addition, IL-1RA-promoted OSCC malignancy involved enhanced properties of cancer stemness via a mitochondrial metabolism-associated EGFR/JNK pathway, which may be suppressed by application of mitochondrial complex inhibitors both in vitro and in vivo (Fig. 8).